Long-term low-dose atorvastatin therapy and prevention of macroangiopathy complications in elderly patients with Type 2 diabetes mellitus
Aim. To study the effectiveness of long-term low-dose atorvastatin therapy in elderly patients with Type 2 diabetes mellitus (DM-2) and dyslipidemia (DLP). Material and methods. In total, 135 elderly patients with DM-2 and DLP were included in the main group (MG), receiving atorvastatin (10—20 mg/d;...
Saved in:
Main Authors: | G. A. Batrak, S. E. Myasoedova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2010-06-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2088 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atorvastatin effectiveness in dyslipidemia correction among coronary heart disease and arterial hypertension patients with high risk of cardiovascular complications
by: E. V. Minakov, et al.
Published: (2007-10-01) -
SPECIFICS OF LIPID METABOLISM AND ATORVASTATIN EFFICACY IN TYPE 2 DIABETES WITH CARRIAGE OF VARIOUS POLYMORPHISMS OF CHOLESTEROL ETHER CARRYING PROTEIN TaqIB GENE
by: M. V. Kim, et al.
Published: (2015-10-01) -
Lipid metabolism correction in elderly patients with Type 2 diabetes mellitus
by: L. G. Gonokhova
Published: (2006-08-01) -
EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE
by: G. A. Batrak, et al.
Published: (2015-09-01) -
Q192R paraoxonase gene 1 (PON1) polymorphism and atorvastatin therapy effect in patients with type 2 diabetes mellitus (T2DM)
by: M. V. Kim, et al.
Published: (2015-03-01)